USANA Health Sciences Inc

Consumer Defensive · Packaged Foods

14.70$ -1.1% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

USANA Health Sciences Inc (USNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 223 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement USNA
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	254	253	255	257	262	273	292	301	297	299	273	256	261	271	267	259	299	311	308	337	274	267	273	264	233	228	248	238	213	221	228	213	200	214	250	236	214	226	250	223	913
Cost of Revenue	161	50	46	48	51	50	54	54	56	53	50	50	51	51	50	51	60	62	61	60	54	56	55	53	50	50	52	47	46	45	46	44	43	43	61	58	49	49	59	48	206
Gross Profit	93	212	209	209	210	223	238	247	241	246	223	206	209	220	217	208	239	248	247	277	220	211	218	212	183	178	197	192	168	176	182	169	157	171	189	178	165	177	191	175	707
Research & Development	0.0	8.8	0.0	0.0	0.0	9.0	0.0	0.0	0.0	10	–	–	–	10	–	–	–	11	–	–	–	11	–	–	–	12	–	–	–	11	–	–	–	12	–	–	–	–	–	–	–
Selling, General & Administrative	61	57	64	62	67	71	70	68	69	68	70	67	66	65	65	61	66	69	72	72	67	69	69	66	66	61	67	68	63	59	64	61	61	73	91	82	86	78	88	82	335
Total Operating Expenses	57	171	176	177	179	187	195	196	195	197	188	175	174	176	178	168	193	196	203	223	180	180	185	182	161	156	170	167	150	152	157	151	142	163	173	161	164	160	177	195	695
Operating Income	36	32	33	32	31	36	43	51	46	49	35	31	35	45	39	40	45	53	44	54	41	32	33	29	23	23	27	24	18	24	25	18	16	8.2	16	17	1.2	17	14	-20	12
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.4
Pre-Tax Income	36	32	33	33	32	36	44	52	47	49	36	33	36	46	39	40	44	55	44	54	40	32	33	29	23	23	29	27	21	27	27	20	19	10	17	19	1.8	4.2	15	-19	2.5
Income Tax Expense	6.0	9.9	12	9.6	8.3	42	15	18	15	17	12	11	12	15	13	12	14	15	14	16	13	11	11	10	8.3	10	10	9.5	9.2	9.8	11	9.8	8.0	5.9	7.4	8.4	8.5	5.8	8.5	9.1	32
Net Income	30	22	21	23	24	-5.9	29	34	31	32	24	21	24	31	27	28	31	40	31	38	27	20	22	19	15	13	18	17	11	17	17	10	11	4.5	9.4	9.7	-6.5	-1.8	7.5	-21	-22
EBITDA	39	35	36	37	35	43	48	55	50	53	41	37	41	52	45	45	51	59	50	60	46	37	39	35	29	28	34	32	26	32	32	26	24	16	27	29	11	15	25	-9.7	42

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings